Advisory Services Network, LLC Agenus Inc Transaction History

Advisory Services Network, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$0.63 - $1.14 $63 - $113	100 New	100 $0
Q1 2023 May 17, 2023	SELL	$1.45 - $2.95 $1 - $2	-1 Reduced 0.04%	2,600 $3,000
Q4 2022 Feb 13, 2023	BUY	$2.02 - $3.25 $5,254 - $8,453	2,601 New	2,601 $6,000
Q3 2021 Nov 05, 2021	SELL	$4.98 - $6.63 $12,454 - $16,581	-2,501 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$2.56 - $5.49 $6,402 - $13,730	2,501 New	2,501 $14,000
Q1 2021 May 24, 2021	SELL	$2.69 - $5.25 $6,725 - $13,125	-2,500 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$2.98 - $5.2 $7,450 - $13,000	2,500 New	2,500 $10,000
Q1 2020 May 15, 2020	SELL	$1.92 - $4.39 $3,840 - $8,780	-2,000 Closed	0 $0
Q4 2019 Feb 04, 2020	BUY	$2.41 - $4.4 $2,410 - $4,400	1,000 Added 100.0%	2,000 $8,000
Q3 2018 Nov 02, 2018	BUY	$1.59 - $2.42 $1,590 - $2,420	1,000 New	1,000 $2,000

2.07M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

Stay updated on Advisory Services Network, LLC with notifications on news.